Tag: biotechnology
-

Sumitomo Dainippon, Biotechs in $3B Acquisition Deal
Japanese pharmaceutical company Sumitomo Dainippon agreed to acquire five biotechnology companies and gain an equity stake in the Roivant Sciences group.
-

Spin-Off Licensing Athletic Microbiome Technology
A company spun-off from biomedical engineering labs at Harvard University is acquiring research on microbial communities in elite athletes to create new probiotics.
-

Gates Investing in HIV, Tuberculosis Immunotherapies
The Bill and Melinda Gates Foundation is taking an equity stake in a biotechnology company developing immunotherapies from messenger RNA.
-

Deep Learning Techniques Speed Drug Discovery
Researchers developed and demonstrated techniques with deep learning to discover new small molecule drugs ready for validation and lab animal tests in 21 days.
-

Infographic – Biotech Index Falls in Summer
It’s time to check in again on the NBI on its ups and downs since the start of 2019, our infographic for this weekend.
-

Companies Call for Genome Editing Regulations
A group of companies developing treatments for disease using genome editing are calling for regulations and standards to govern these technologies in regenerative medicine.
-

Small Biz Grant Funds Pre-Term Gut Microbe Therapy
National Institutes of Health is supporting development of an extended-release probiotic treatment for necrotizing enterocolitis, an intestinal disease affecting premature infants.
-

Carb-X Funds Drug-Resistant Bacterial Vaccine
A company developing vaccines with synthetic biology is receiving a grant for a vaccine to prevent infections from drug-resistant Klebsiella pneumoniae bacteria.
-

FDA Okays Celiac Disease Engineered Microbe Trial
A company making synthetic biological therapies received authorization to begin clinical trials in the U.S. for an engineered microbe to treat celiac disease.
-

Controlled Brain Tumor Gene Therapy Shown Safe
A clinical trial shows an experimental gene therapy that controls release of a powerful anti-tumor protein is safe for patients with stubborn glioblastoma, a type of brain cancer.